Twist Bioscience (TWST)

• Market cap: $1.66B
• 1 day: 0.29%
• 5 days: -0.15%
• 1 month: -24.80%
• 3 months: -6.60%
• 6 months: -33.53%
• Year to date: -39.37%
• 1 year: -37.54%
• 5 years: -59.56%
• 10 years: 96.21%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Employees: 923

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

66% more call options, than puts

Call options by funds: $2.44M | Put options by funds: $1.47M

1.8% more ownership

Funds ownership: 116.56% [Q1] → 118.35% (+1.8%) [Q2]

4% less capital invested

Capital invested by funds: $2.73B [Q1] → $2.61B (-$121M) [Q2]

8% less repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 85

10% less funds holding

Funds holding: 260 [Q1] → 235 (-25) [Q2]

33% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 52

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]